COVID-19 Vaccine Hesitancy Among Parents: A Qualitative Study
- PMID: 37867449
- PMCID: PMC10598621
- DOI: 10.1542/peds.2023-062466
COVID-19 Vaccine Hesitancy Among Parents: A Qualitative Study
Abstract
Objectives: Addressing parental/caregivers' coronavirus disease 2019 (COVID-19) vaccine hesitancy is critical to improving vaccine uptake in children. Common concerns have been previously reported through online surveys, but qualitative data from KII and focus groups may add much-needed context. Our objective was to examine factors impacting pediatric COVID-19 vaccine decision-making in Black, Spanish-speaking, and rural white parents/caregivers to inform the content design of a mobile application to improve pediatric COVID-19 vaccine uptake.
Methods: Parents/caregivers of children aged 2 to 17 years from groups disproportionately affected by COVID-19-related vaccine hesitancy (rural-dwelling persons of any race/ethnicity, urban Black persons, and Spanish-speaking persons) were included on the basis of their self-reported vaccine hesitancy and stratified by race/ethnicity. Those expressing vaccine acceptance or refusal participated in KII, and those expressing hesitancy in focus groups. Deidentified transcripts underwent discourse analysis and thematic analysis, both individually and as a collection. Themes were revised until coders reached consensus.
Results: Overall, 36 participants completed the study: 4 vaccine acceptors and 4 refusers via KIIs, and the remaining 28 participated in focus groups. Participants from all focus groups expressed that they would listen to their doctor for information about COVID-19 vaccines. Infertility was a common concern, along with general concerns about vaccines. Vaccine decision-making was informed by the amount of information available to parents/caregivers, including scientific research; possible positive and negative long-term effects; and potential impacts of vaccination on preexisting medical conditions.
Conclusions: Parents/caregivers report numerous addressable vaccine concerns. Our results will inform specific, targeted interventions for improving COVID-19 vaccine confidence.
Copyright © 2023 by the American Academy of Pediatrics.
Conflict of interest statement
Comment in
-
It's Time for a National Surveillance System for Vaccine Confidence and Hesitancy.Pediatrics. 2023 Nov 1;152(5):e2023063169. doi: 10.1542/peds.2023-063169. Pediatrics. 2023. PMID: 37867453 Free PMC article. No abstract available.
References
-
- American Academy of Pediatrics. Children and COVID-19: state-level data report. Available at: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/.... Accessed March 17, 2023
-
- Centers for Disease Control and Prevention. Provisional COVID-19 deaths: focus on ages 0-18 years. Available at: https://data.cdc.gov/NCHS/Provisional-COVID-19-Deaths-Focus-on-Ages-0-18.... Accessed March 17, 2023
-
- Fowlkes AL, Yoon SK, Lutrick K, et al. . Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA vaccine in preventing SARS-CoV-2 infection among children aged 5–11 years and adolescents aged 12–15 years–PROTECT Cohort, July 2021–February 2022. MMWR Morb Mortal Wkly Rep. 2022;71(11):422–428 - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
